Effect of vitamin B12 and folate on homocysteine levels in colorectal cancer

Indian Journal of Clinical Biochemistry

Volumn 23, Issue 3, 2008, Pages 258-261

  Chandy, Sunil ^a   Adiga, M N Sadananda ^a   Ramaswamy, Girija ^a   Ramachandra, C ^a   Krishnamoorthy, Lakshmi ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Colorectal cancer; Folate; Homocysteine; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CASE CONTROL STUDY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; EVALUATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MALE; VITAMIN BLOOD LEVEL;

EID: 56849119374     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-008-0058-7     Document Type: Article

References (28)

1. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22:4632-42.
2. Allen RH, Stabler SP, Savage DG. Diagnosis of cobalamin deficiency I. Usefulness of serum methylmalonic acid and total homocysteine concentrations Am J Hematol 1990; 34: 90-8.
3. Gershoni-Baruch R, Dagan E, Israeli D. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 2000; 36:2313-16.
4. Miao X, Xing D, Tan W, Qi J, Lu W, Lin D. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk chinese population. Cancer Epidemiol Biomarkers Prev 2002; 11:1454-58.
5. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greves MF. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci.U S A 2001; 98:4004-09.
6. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56:4862-64.
7. Frantzen F, Faaren AL, Aifheim I, Nordhei AK. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998;44(2):311-16.
8. 12 and Folic acid. Clin Chem 1977; 23(9): 1609-14.
9. Kim Y I. Folate and carcinogenesis: evidence, mechanisms and implications. J Nutr 1999; 10:62-88.
10. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocytic DNA methylation in postmenopausal women. J Nutr 1998; 128:1204-12.
11. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000; 130:129-32.
12. Blount BC, Mack MM, Wehr CM, Hiatt RA, Wang G, Wickramasinghe SN et al. Foalte deficiency causes uracil misincorporation into human DNA and chromosome brekage: Implication for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94:3290-95.
13. 12, homocysteine status and chrosome damage rate in lymphocytes of older men. Carcinogenesis 1997; 18: 1329-36.
14. 12 homocysteine status and DNA damage in young Australian adults. Carcinogenesis 1998; 19:1163-71.
15. Ma J, Stampfer MJ, Giovanucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and of colorectal cancer. Cancer Res 1997; 57:1098-102.
16. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999; 8:513-18.
17. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al . Polymorphisms in the methylene tetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96: 12810-15.
18. Wiemels JL, Smith RN, Tylor GM, Eden OB, Alexander FE, Greaves MF. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98: 4004-09.
19. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298 C mutations. Am J Human Genet 2000; 67:986-90.
20. Kumar J, Das SK, Sharma P, Karthikeyan G, Ramakrishnan L, Sengupta S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 2005; 50:655-63.
21. Powers HJ. Interaction among folate, riboflavin, genotype and cancer with reference to colorectal and cervical cancer. J Nutr 2005; 135(Suppl):2960-66.
22. Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Stenling R, Riboli J, etal. Low folate levels may protect against colorectal cancer. Gut 2006; 55:1461-66.
23. Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case - control study in Taiwan. Carcinogenesis 2006; 27:2295-300.
24. Marugame T, Tsuji E, Kiyohara C. Relation of plasma folate and Methylenetetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol 2003; 32: 64-6.
25. Vlajinac HD, Marinkovic JM, Ilic MD, Koeev NI. Diet and prostate cancer: a case -control study. Eur J Cancer 1997; 33: 101-07.
26. Stevens VL, McCullaigh ML, Diver WR. Use of multivitamins and prostate cancer mortality in a large cohort of US men. Cancer Causes Control 2005; 16: 643-50.
27. 12 in Lung cancer. J Environ Pathol Toxicol Oncol 1996; 15:161-67.
28. 12 and folate with lung cancer risk in older men. Am J Epidemiol 2001; 153: 688-94.